NASDAQ

Artiva Biotherapeutics, Inc. (ARTV)

♥ 587 Thanks from members

Live price chart, market sentiment, and community perspectives for Artiva Biotherapeutics, Inc. (NASDAQ: ARTV).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Artiva Biotherapeutics TeamLeadership: Fred Aslan (CEO)Leadership: Valerie Wick (CFO)Holder: 5AM VenturesHolder: RA Capital ManagementHolder: Woodline PartnersAllogeneic NK Cell PlatformAB-101AB-201#ARTV#Artiva Biotherapeutics#NK cell therapy#autoimmune disease#biotech IPO